Emergent BioSolutions Inc (NYSE:EBS)

28.70
Delayed Data
As of 11:39am ET
 -0.48 / -1.64%
Today’s Change
19.31
Today|||52-Week Range
30.96
+5.40%
Year-to-Date

Today’s Trading

Previous close29.18
Today’s open29.09
Day’s range28.58 - 29.25
Volume63,386
Average volume (3 months)257,153
Market cap$1.1B
Dividend yield--
Data as of 11:39am ET, 03/31/2015

Growth & Valuation

Earnings growth (last year)+3.53%
Earnings growth (this year)-33.83%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+8.49%
P/E ratio35.8
Price/Sales3.00
Price/Book1.99

Competitors

 Today’s
change
Today’s
% change
KPTIKaryopharm Therapeut...-0.77-2.49%
ALDRAlder Biopharmaceuti...-0.37-1.25%
ARNAArena Pharmaceutical...-0.08-1.79%
PRTAProthena Corporation...-1.76-4.47%
Data as of 11:54am ET, 03/31/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)-$0.54
Annual revenue (last year)$339.3M
Annual profit (last year)$36.7M
Net profit margin10.83%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. Abdun-Nabi
CFO, Treasurer &
Executive VP-Corporate Services
Robert G. Kramer
Corporate headquarters
Rockville, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account